Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Keil F, Prinz E, Kalhs P, Lechner K, Moser K, Schwarzinger I, Jäger U, Fonatsch C, Worel N, Mannhalter C, Rabitsch W, Loidolt H, Schulenburg A, Mitterbauer M, Höcker P, Greinix HT. Keil F, et al. Among authors: fonatsch c. Leukemia. 2001 Mar;15(3):355-61. doi: 10.1038/sj.leu.2402048. Leukemia. 2001. PMID: 11237057
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Greinix HT, Loidolt H, Rabitsch W, Schulenburg A, Keil F, Mitterbauer M, Laczika K, Lechner K, Dieckmann K, Fischer G, Jäger U, Rosenmayr A, Knöbl P, Schwarzinger I, Höcker P, Mannhalter C, Hinterberger W, Haas OA, Fonatsch C, Kalhs P. Greinix HT, et al. Among authors: fonatsch c. Ann Hematol. 2000 Apr;79(4):206-13. doi: 10.1007/s002770050580. Ann Hematol. 2000. PMID: 10834508 Clinical Trial.
Prognosis of patients with a second relapse of acute myeloid leukemia.
Stoiser B, Knöbl P, Fonatsch C, Haas OA, Mitterbauer G, Weltermann A, Geissler K, Valent P, Sperr W, Pabinger I, Lechner K, Jaeger U. Stoiser B, et al. Among authors: fonatsch c. Leukemia. 2000 Dec;14(12):2059-63. doi: 10.1038/sj.leu.2401968. Leukemia. 2000. PMID: 11187893
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K, Mitterbauer G, Mitterbauer M, Knöbl P, Schwarzinger I, Greinix HT, Rabitsch W, Fonatsch C, Mannhalter C, Lechner K, Jaeger U. Laczika K, et al. Among authors: fonatsch c. Leuk Lymphoma. 2001 Sep-Oct;42(5):923-31. doi: 10.3109/10428190109097711. Leuk Lymphoma. 2001. PMID: 11697647 Clinical Trial.
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Weltermann A, Fonatsch C, Haas OA, Greinix HT, Kahls P, Mitterbauer G, Jäger U, Kainz B, Geissler K, Valent P, Sperr WR, Knöbl P, Schwarzinger I, Gleiss A, Lechner K. Weltermann A, et al. Among authors: fonatsch c. Leukemia. 2004 Feb;18(2):293-302. doi: 10.1038/sj.leu.2403243. Leukemia. 2004. PMID: 14671635
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors.
Greinix HT, Reiter E, Keil F, Fischer G, Lechner K, Dieckmann K, Leitner G, Schulenburg A, Hoecker P, Haas OA, Knoebl P, Mannhalter C, Fonatsch C, Hinterberger W, Kalhs P. Greinix HT, et al. Among authors: fonatsch c. Bone Marrow Transplant. 1998 Apr;21(7):673-8. doi: 10.1038/sj.bmt.1701152. Bone Marrow Transplant. 1998. PMID: 9578306
255 results